Results 171 to 180 of about 3,150,566 (296)
Influence of Contrast Media on Alcoholic Sympathectomy [PDF]
Duk Hwa Choi +6 more
openalex +1 more source
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir +12 more
wiley +1 more source
Prevention of contrast induced nephropathy; a cardiology point of view [PDF]
Hashemi Mohammad +2 more
doaj
Acute Adverse Reactions to Nonionic Low-Osmolar Iodinated Contrast Media in Children: A Retrospective Study of 23,429 Injections Over 6 Years. [PDF]
Seong Y +9 more
europepmc +1 more source
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
Performance Evaluation of a Custom-Designed Contrast Media Injector in a 5-Tesla MRI Environment. [PDF]
Hu Y +8 more
europepmc +1 more source
Central effects of iohexol and iopamidol, non-ionic contrast media.
Kensuke Kisara +7 more
openalex +2 more sources
Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia +9 more
wiley +1 more source
Characterization of Hypersensitivity to Iodinated Contrast Media: Insights from a Six-Year Cohort of 26,465 Procedures. [PDF]
Pinyopornpanish K +4 more
europepmc +1 more source

